This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Through a new deal, Roche has exclusive rights to Sangamo molecules designed to repress the gene that makes “tau,” a protein many scientists view as a main driver of Alzheimer’s.
A move by Optum to change longstanding practices for licensing data to academic institutions has sparked an outcry among researchers, who argue the move will make accessing data so costly and difficult that universities will scale back their research programs.
A federal patent board ruled Broad Institute scientists were first to a key gene editing advance, weakening the patent position of Intellia and CRISPR Therapeutics, which hold licenses through the University of California.
If you enjoy working with biological samples and are enthusiastic about healthcare, a career as a clinical scientist might be just right for you. To start applying to clinical scientist jobs today, head over to the Xtalks Job Search platform. Who is a Clinical Scientist? What is it Like to Work as a Clinical Scientist?
A field application scientist is a valuable member of any life science company due to their direct interaction with customers. Field application scientists help laboratory groups successfully install and apply the newest scientific supplies, equipment, instruments and software. Field Scientist Job Description.
BEIJING — Hong Kong on Tuesday revoked a visa it granted to a Chinese scientist who set off an ethical debate five years ago with claims that he made the world’s first genetically edited babies, pulling it hours after he announced his research plans in the financial hub. Read the rest…
According to the US government, Gilead had repeatedly refused to license patents related to PrEP research undertaken by the Department of Health and Human Services’ (HHS) Centers for Disease Control and Prevention (CDC). This research dates to the mid-2000s when CDC scientists developed the PrEP regimen, argued the government.
DEA agents interviewed former Cerebral employees about clinician licensing issues and allegations that some patients had set up multiple accounts to obtain more drugs, Insider reported , citing sources. The number of mental health apps vetted by scientists pales compared to the plethora out there. Here’s a great example.
Coya Therapeutics has expanded its patent estate for COYA 301 by entering a licensing agreement with UNeMed, the University of Nebraska Medical Center’s technology transfer office. Coya secured exclusive patent rights and intellectual property rights related to COYA 301 and combinations to treat Parkinson’s disease (PD).
Under the deal, Merck will license its VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform. As per the collaboration, Merck will provide technical support, training and process development and streamlining to Synplogen’s scientists at its M Lab Collaboration Center located in Tokyo, Japan.
The lack of a placebo group makes it hard to say definitively that the changes in brain activity were due to the game, but the scientists hope to address that in follow-up studies. “We look forward to continuing to learn about how the digital therapeutic can help children with ADHD in their daily lives.”
Anima uses its mRNA Lightning platform to discover small molecules and determine their mechanisms of action for diseases previously deemed undruggable, with scientists searching for compounds that target proteins with roles in regulating mRNA, so as to affect disease states through post-transcriptional regulation (i.e.
Using CytomX’s Probody and Regeneron’s Veloci-Bi platforms, the collaboration and licensing agreement aims to enable the development of investigational next-generation bispecific immunotherapies. Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc.
today announced a new four-year open access agreement with IReL, an e-resource licensing consortium for Irish institutions, to accelerate open access publishing and increase visibility for more than 150,000 students and researchers across Ireland. March 18, 2021 – Hoboken, N.J. – John Wiley & Sons, Inc.
Scientist invents novel device to conveniently sanitize contaminated masks at home or at work Credit: Patrick Grant, Ph.D., Florida Atlantic University COVID-19 has significantly increased public use of face masks to protect others from the wearer’s respiratory droplets as well as the wearer from airborne contaminants.
In the UK, licensed forms of melatonin are prescribed either for the management of insomnia in adults over 55 years of age or to help with jet lag. Cochrane Collaboration (a world-wide collaboration of scientists) looked at the effectiveness of melatonin in the management o jet lags. Slenyto tablets have a specific licensed use.
At the moment scientists only have the top-line data from press releases to go on so it is impossible to make any judgments about the relative efficacy of the two vaccines, or indeed the two mRNA-based shots from Pfizer/BioNTech and Moderna that have also shown efficacy rates above 90% in clinical trials. So far it has accepted orders for 1.2
The FDA oversees all drug approvals in the US via New Drug Applications (NDAs), with approvals for biologic products being approved via Biologics License Applications (BLAs). Regulatory Scientist. The drug approval process represents one of the most obvious differences between US and EU agencies. Author: Dominika Trzilova, PhD.
Cell therapy research has been built on collaborations amongst scientists and entrepreneurs, providing early proof of concept for modalities thought to be too difficult to commercialise but with a strong potential for patient benefit”.
Following that hypothesis, scientists designed oral inhibitors, which could target mitochondrial DNA (mtDNA). Atsena took the candidate from Sanofi earlier this year that licensed it from UF. Scientists at Neuron23, since October 2018, have worked to discover their place in the world of precision medicine.
There are a lot of scientists who want to better understand biology but don’t have the money to do it in wet settings. The tandem of AI and translational scientists can then find the strongest signals and figure out why those targets worked. So what do they do? They go into bioinformatics”.
The South African hub aims to provide a facility where manufacturers from low- and middle-income countries receive training in producing certain vaccines and the licenses to do so. To begin to satiate this need, in June of last year, the WHO announced the establishment of the United Nations (UN) mRNA technology transfer hub in South Africa.
The company, Cellinta Limited, was born out of research from scientists at the University of Edinburgh, and received funding through investments from SV Health Investors and Cancer Research UK. The funding will be used to develop a pipeline of ‘highly selective’ gene therapies targeting cancer stem cells in a variety of solid tumour types.
Over the past five years, the life sciences sector produced a total of 83 commercialised or licensed products and services. In fact, Hamilton boasts more than 6,700 professional scientists, researchers and clinicians in over 50 research institutes and centres.
This product was developed by uniQure prior to being licensed to CSL Behring. In simple terms from a non-scientist, these gene therapies add functional versions of genes to patients that do not have them, and thus the idea is to have these genes function in the same way as they do in individuals without these disorders.
COSMIC isn’t the only database trying to provide these links between mutations and drugs, but is one of the few with a dedicated, full-time team of scientists keeping it updated, according to Steve Jupe, who heads the Actionability team at Wellcome Sanger.
Redx Pharma’s Lisa Anson talked about the company’s multi-million global licensing deal with pharma giant AstraZeneca, which will further develop and commercialise its treatment for sufferers of fibrotic diseases, and its other recent fundraising milestones.
Patients can only access SparkRx through a licensed healthcare provider. She’s a cognitive and behavioural scientist by training, having received her PhD in Psychology & Neuroscience from Duke University and completed a translational psychology postdoctoral fellowship at UCLA.
For the past 50 years, scientists have used manmade, synthetic and nucleoside analogues to create drug therapies for diseases that involve the cellular division and/or the viral reproduction of […].
By harnessing our game-changing AI capabilities, we hope to help Sanofi’s scientists identify novel and personalised targets in IBD, and to prioritise targets in their pipeline.” David Harel, CEO and co-founder of CytoReason, said: “It’s exciting to see the growing adoption of our technology by world-leading pharma companies.
Among the claims is that Comirnaty was developed using a chemical modification to prevent causing an unwanted immune response in patients which was discovered by Moderna scientists, and that the use of a lipid nanoparticle formulation also infringes its intellectual property.
As research developments into RNA vaccines help scientists accelerate drug candidates to arm the immune system against coronavirus, Pharma IQ ’s Keeping tabs on Covid-19 update returns with news from some of the biotechnology innovators leading the fight against the global pandemic.
Damour’s co-founders are ADC scientist Paul Jackson – formerly of King’s College London – who will serve as vice president of R&D, as well as Jackson’s former boss at KCL, Prof David Thurston, who will act as an advisor to the new company.
South Korea’s Hanlim Pharmaceuticals has licensed the drug candidate and RudaCure aims to get approvals for both phase 1 clinical trials in South Korea and phase 2 clinical trials in the US this year. They’re currently on the hunt for more global licensing partners for RCI001. Everyone in our team is very valuable,” he said.
Fortunately, as a member of the Novartis Business Development & Licensing (BD&L) department, she was in a position to try to help. Jennifer Leeds , Head of West Coast Search and Evaluation, NIBR Business Development & Licensing. Knowing that a pandemic was likely coming made watching the crisis unfold no less heartbreaking.
The licensing agreement comes almost two years after Roche dropped the tumor microenvironment modulator after putting it through a clutch of early-phase studies in solid tumor patients. Now, scientists have elucidated a potential use for the protein in cancer treatment. Roche offloads clinical-phase cancer drug to Celleron.
The scientist is primarily responsible for developing the clinical strategy for a trial. In some organizations, the project manager also plays the role of the scientist. Budget monthly or annual license fees associated with these systems. Individuals with Ph.D. degrees are usually the right fit for this role. Biostatistician.
Scientists will be testing a drug class targeting the C-reactive protein (CRP) marker of acute inflammation in the body. Early data is enabling the scientists to narrow groups of drug-like compounds that may work best, but these must be optimized to block the CRP effectively. Monoclonal Antibodies. New Immune System Cell.
After more than 50 years of research, we are closer than ever to having a licensed CMV vaccine,” Permar said. Related: Pneumococcal Vaccination for Adults: Conversation with Vaccine Scientists Dr. Heather Platt and Dr. Ulrike Buchwald from Merck – Xtalks Life Science Podcast Ep.
I want to thank all my Pfizer colleagues who have worked tirelessly to make this moment possible: from our scientists in vaccine research and development, to our experts in manufacturing and supply. And I want to thank our global health partners for their tireless commitment to such an important goal.
In our experience, FDA is inherently an empirically driven body of scientists, physicians, and policy-makers. 42 U.S.C. § 262(k)(2)(A)(i)(I). It will likely take time to supplant decades of reliance upon existing animal testing methods used to investigate drug pharmacology and toxicology.
Yesse Technologies scientists recently validated the presence of a distinctive smell, arising from an oily skin secretion called sebum, in patients diagnosed with Parkinson’s disease. Fox Foundation for Parkinson ‘s Research. “We are thrilled that The Michael J.
Bayer is a main sponsor of the event, which invites scientists and industry leaders to discuss the latest achievements and developments in horticulture. It is licensed for commercial use by Ecología y Protección Agricola (EPA) in Valencia and provides 400 days of pest control.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content